Page 22 - Cardiac Nursing

6
/
6
d
6
/
/
09
/
30
30
d
i.
i.
i.
vii
vii
q
x
x
x
q
q
09
xvi
A
xvi
e
e
A
tar
tar
p
p
p
g
13
13
13
1:
1:
PM
g
g
Pa
PM
Pa
LWBK340-F0-FM_
LWB K34 0-F M_ p p ppi-xviii.qxd 6/30/09 1:13 PM Page xvi Aptara a a
i-x
LWB
M_
0-F
K34
i-x
xvi Contents
CO Measurement 485 CHAPTER 24
Continuous Cardiac Output 487
Less Invasive Methods for CO Monitoring 488 Heart Failure and Cardiogenic Shock 555
Oxygen Supply and Demand 492
Laurie A. Soine
Heart Failure 555
Cardiogenic Shock 578
IV CHAPTER 25
PA R T
Cardiac Surgery 595
Pathophysiology and Management of Denise Ledoux • Helen Luikart
Heart Disease 511
Evolving Trends in Cardiac Surgery 595
Preoperative Assessment and Preparation 595
CHAPTE R 22 Surgical Techniques 596
Cardiac Surgery Procedures for Coronary Artery
Acute Coronary Syndromes 511 Revascularization 597
Cardiac Surgery Procedures for Acquired Structural Heart
Jean Marie Blue Verrier •
Disease 600
Michaelene Hargrove Deelstra
Cardiac Transplantation 606
Presentation of ACS 511
Initial Evaluation and Management of Patients CH A PTER 26
with ACS 512
Coronary Revascularization Strategies and Reperfusion Mechanical Circulatory Assist Devices 623
Therapies 516 Michael A. Chen
Reperfusion Strategies for STEMI and UA/NSTEMI 521
Pharmacological Management of ACS 523 Intra-Aortic Balloon Pump Counterpulsation 623
Complications of MI 527 Other Mechanical Circulatory Assist Devices 628
Nursing Management of ACS 528
Nursing Management of Patients with RV Infarction 531 C H A PTER 27
C HAPTE R 23 Sudden Cardiac Death and Cardiac
Arrest 638
Interventional Cardiology Donna Gerity
Techniques: Percutaneous Definition of Sudden Death 638
Coronary Intervention 537 Pathophysiology and Cause of SCA 638
Michaelene Hargrove Deelstra Management of SCA 641
Survivors of Cardiac Arrest 649
Patient Selection for PCI 537
Percutaneous Transluminal Coronary Angioplasty 538 C H A PTER 28
Coronary Atherectomy, Atheroablative, and Thrombectomy
Devices 539 Pacemakers and Implantable Defibrillators 655
Coronary Stents 540
Management of the Patient During PCI 542 Carol Jacobson • Donna Gerity
Anticoagulation Options for PCI 544 Pacemakers 655
Complications Associated with PCI 544 Implantable Cardioverter Defibrillators 683
Restenosis 547 Conclusion 701
Adjunctive Modalities: Quantitative Angiography 548
Noncoronary Devices for Treatment of Congenital Heart C HAPTER 29
Defects 548
Future Directions for PCI 550 Acquired Valvular Heart Disease 705
Nursing Management of Patients Undergoing PCI 550
Denise Ledoux
ECF Deficit Related to Contrast-Induced Diuresis,
Restricted Oral Intake, Hemorrhage from Delayed Definition, Classification, and Epidemiology705
Coagulation 551 Causes of Acquired Valvular Heart Disease 705